Literature DB >> 18195031

Development of Galleria mellonella as an alternative infection model for the Burkholderia cepacia complex.

Kimberley D Seed1, Jonathan J Dennis.   

Abstract

Burkholderia is an important bacterial genus with a complex taxonomy that contains species of both ecological and pathogenic importance, including nine closely related species collectively termed the Burkholderia cepacia complex (BCC). In order to more thoroughly investigate the virulence of this bacterial complex of microorganisms, alternative infection models would be useful. To this end, we have adapted and developed the use of the Galleria mellonella wax moth larvae as a host for examining BCC infections. The experimental conditions affecting the BCC killing of the "wax worm" were optimized. BCC virulence levels were determined using 50% lethal doses, and differences were observed between both species and strains of the BCC. The BCC pathogenicity trends obtained compare favorably with results acquired using other published alternative infection models, as well as mammalian infection models. In addition, BCC killing activity was determined by directly measuring relative bacterial loads in three different BCC strains, thus demonstrating innate differences in BCC strain virulence. Finally, genetically mutated BCC strains were compared to a wild-type BCC strain in order to show concomitant reduction of BCC virulence and increased wax worm survival. For experimentation examining the virulent properties of the BCC, the wax worm has proven to be a useful alternative infection model.

Entities:  

Mesh:

Year:  2008        PMID: 18195031      PMCID: PMC2258804          DOI: 10.1128/IAI.01249-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  49 in total

Review 1.  Taxonomy and identification of the Burkholderia cepacia complex.

Authors:  T Coenye; P Vandamme; J R Govan; J J LiPuma
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

2.  Correlation between virulence of Candida albicans mutants in mice and Galleria mellonella larvae.

Authors:  Marc Brennan; David Y Thomas; Malcolm Whiteway; Kevin Kavanagh
Journal:  FEMS Immunol Med Microbiol       Date:  2002-10-11

3.  Use of the Galleria mellonella caterpillar as a model host to study the role of the type III secretion system in Pseudomonas aeruginosa pathogenesis.

Authors:  Sachiko Miyata; Monika Casey; Dara W Frank; Frederick M Ausubel; Eliana Drenkard
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

4.  Differential persistence among genomovars of the Burkholderia cepacia complex in a murine model of pulmonary infection.

Authors:  Karen K Chu; Donald J Davidson; T Keith Halsey; Jacqueline W Chung; David P Speert
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

5.  Killing of Caenorhabditis elegans by Burkholderia cepacia is controlled by the cep quorum-sensing system.

Authors:  Manuela Köthe; Melanie Antl; Birgit Huber; Kilian Stoecker; Doreen Ebrecht; Ivo Steinmetz; Leo Eberl
Journal:  Cell Microbiol       Date:  2003-05       Impact factor: 3.715

6.  Burkholderia cenocepacia sp. nov.--a new twist to an old story.

Authors:  Peter Vandamme; Barry Holmes; Tom Coenye; Johan Goris; Eshwar Mahenthiralingam; John J LiPuma; John R W Govan
Journal:  Res Microbiol       Date:  2003-03       Impact factor: 3.992

7.  Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.

Authors:  A Isles; I Maclusky; M Corey; R Gold; C Prober; P Fleming; H Levison
Journal:  J Pediatr       Date:  1984-02       Impact factor: 4.406

Review 8.  Burkholderia cepacia complex infection in patients with cystic fibrosis.

Authors:  Eshwar Mahenthiralingam; Adam Baldwin; Peter Vandamme
Journal:  J Med Microbiol       Date:  2002-07       Impact factor: 2.472

Review 9.  Lung infections associated with cystic fibrosis.

Authors:  Jeffrey B Lyczak; Carolyn L Cannon; Gerald B Pier
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

10.  Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada.

Authors:  David P Speert; Deborah Henry; Peter Vandamme; Mary Corey; Eshwar Mahenthiralingam
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

View more
  70 in total

1.  Overcoming an Extremely Drug Resistant (XDR) Pathogen: Avibactam Restores Susceptibility to Ceftazidime for Burkholderia cepacia Complex Isolates from Cystic Fibrosis Patients.

Authors:  Krisztina M Papp-Wallace; Scott A Becka; Elise T Zeiser; Nozomi Ohuchi; Maria F Mojica; Julian A Gatta; Monica Falleni; Delfina Tosi; Elisa Borghi; Marisa L Winkler; Brigid M Wilson; John J LiPuma; Michiyoshi Nukaga; Robert A Bonomo
Journal:  ACS Infect Dis       Date:  2017-03-30       Impact factor: 5.084

Review 2.  A decade of Burkholderia cenocepacia virulence determinant research.

Authors:  Slade A Loutet; Miguel A Valvano
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

3.  Experimental bacteriophage therapy increases survival of Galleria mellonella larvae infected with clinically relevant strains of the Burkholderia cepacia complex.

Authors:  Kimberley D Seed; Jonathan J Dennis
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

4.  Burkholderia cenocepacia creates an intramacrophage replication niche in zebrafish embryos, followed by bacterial dissemination and establishment of systemic infection.

Authors:  Annette C Vergunst; Annemarie H Meijer; Stephen A Renshaw; David O'Callaghan
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

5.  Comparative transcriptomic analysis of the Burkholderia cepacia tyrosine kinase bceF mutant reveals a role in tolerance to stress, biofilm formation, and virulence.

Authors:  Ana S Ferreira; Inês N Silva; Vítor H Oliveira; Jörg D Becker; Michael Givskov; Robert P Ryan; Fábio Fernandes; Leonilde M Moreira
Journal:  Appl Environ Microbiol       Date:  2013-02-22       Impact factor: 4.792

6.  Diversity of potential pathogenicity and biofilm formation among Burkholderia cepacia complex water, clinical, and agricultural isolates in China.

Authors:  Muhammad Ibrahim; Qiaomei Tang; Yu Shi; Abdulwareth Almoneafy; Yuan Fang; Liuhu Xu; Wen Li; Bin Li; Guan-Lin Xie
Journal:  World J Microbiol Biotechnol       Date:  2012-02-09       Impact factor: 3.312

7.  Identification of Burkholderia cenocepacia strain H111 virulence factors using nonmammalian infection hosts.

Authors:  Stephan Schwager; Kirsty Agnoli; Manuela Köthe; Friederike Feldmann; Michael Givskov; Aurelien Carlier; Leo Eberl
Journal:  Infect Immun       Date:  2012-10-22       Impact factor: 3.441

8.  Azithromycin effectiveness against intracellular infections of Francisella.

Authors:  Saira Ahmad; Lyman Hunter; Aiping Qin; Barbara J Mann; Monique L van Hoek
Journal:  BMC Microbiol       Date:  2010-04-23       Impact factor: 3.605

9.  Drosophila melanogaster as a model host for the Burkholderia cepacia complex.

Authors:  Josée Castonguay-Vanier; Ludovic Vial; Julien Tremblay; Eric Déziel
Journal:  PLoS One       Date:  2010-07-12       Impact factor: 3.240

10.  Inactivation of Burkholderia cepacia complex phage KS9 gp41 identifies the phage repressor and generates lytic virions.

Authors:  Karlene H Lynch; Kimberley D Seed; Paul Stothard; Jonathan J Dennis
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.